3ZIFF M, KIBRICK A, DRESNER E,et al, Excretion of hydroxyproline in patients with rheumatic and non-rheumatic diseases[ j ]. J Clin Invest,1956,35(6) :579 -587.
4[2]金泰廙.职业卫生与职业医学[M].第5版.北京:人民卫生出版社,2004:248～272.
5[4]Brooke T.Mossm AN,Andrew Churg.Mechanisms in the pathogenesis of asbestosis and silicosls[J].Am J Respir Crit Care Med,1998,157(5PT1):1666～1680.
6[5]Nikos oikonomou,Vaggelis Harokopos,et al.Soluble TNF mediates the transition from pulmonary inflammation to fibrosis[J].Plos One,2006,1(1):E108.
7[9]Ziff M,Kibrick A,et al.excretion of hydroxyprolinc in nanellts with rheumatic and non-rheumatic disease[J].J Clin Invest.1956,35:579～587.
